Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries Limited Ordinary Shares
(NY:
TEVA
)
40.39
UNCHANGED
Delayed Quote
Updated: 7:00 PM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries Limited Ordinary Shares
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
35
36
Next >
World Markets News For Monday
↗
February 14, 2022
European markets were down over fear of Ukrainian battles.
Via
Talk Markets
Nuclear Winter
↗
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Inflation inflating
↗
February 10, 2022
The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.
Via
Talk Markets
Dampening Exuberance
↗
February 09, 2022
The bond sell-off halted today but the Fed's plans mean this will resume.
Via
Talk Markets
Why Are Teva Pharmaceutical Shares Trading Higher Today?
↗
February 09, 2022
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)
Via
Benzinga
The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical
↗
February 09, 2022
Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled.
Via
Investor's Business Daily
Earnings Scheduled For February 9, 2022
↗
February 09, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.
Via
Benzinga
Price To Earnings Ratio Insights For Teva Pharmaceutical
↗
February 07, 2022
Via
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
↗
February 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Teva Pharmaceutical: Q4 Earnings Insights
↗
February 09, 2022
Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
February 09, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Markets News for Tuesday
↗
February 08, 2022
Oil stocks are up on huge gains.
Via
Talk Markets
Teva, Texas Enter $225M Opioid Settlement Agreement
↗
February 07, 2022
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a
Via
Benzinga
Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims
February 07, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
↗
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Weakened Tech Stocks
↗
February 03, 2022
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks.
Via
Talk Markets
World Markets News for Wednesday
↗
February 02, 2022
Gold and the Euro are up as the greenback loses traction.
Via
Talk Markets
World Markets News for Tuesday
↗
February 01, 2022
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.
Via
Talk Markets
Research Finds COVID Pandemic Worsened Health Equity Gap
February 01, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Drug Troubles
↗
January 28, 2022
The drug sector has both good news and bad.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
↗
January 27, 2022
Upgrades
Via
Benzinga
The Best REITs To Buy Right Now Will Pay 8.5% Yield
↗
January 25, 2022
Stocks had a great 2021, if a tad wild - the S&P 500 finished up nearly 27% for the year. But the performance of real estate investment trusts (REITs) last year flat-out blew stocks out of the water -...
Via
Talk Markets
7 Stocks to Buy That Are Nowhere Near Being Overvalued
↗
January 18, 2022
These stocks to buy are above their lows and appear overvalued. They have more upside as growth drivers emerge lifting their prospects.
Via
InvestorPlace
Chopped Stocks
↗
January 18, 2022
The day's theme is sell tech and buy banks.
Via
Talk Markets
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022
January 18, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
More Serious Matters
↗
January 14, 2022
Wall Street fell on new worries about inflation and a drop in retail sales levels.
Via
Talk Markets
Two Curses Of The Current Year
↗
January 13, 2022
The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%.
Via
Talk Markets
Start Of The Week
↗
January 10, 2022
British property (real estate) stocks fell today.
Via
Talk Markets
Post-Fed Thursday
↗
January 06, 2022
Companies earning in dollars but incorporated abroad and paying dividends in other currencies were big gainers today.
Via
Talk Markets
Good Deed Turns Sour
↗
January 05, 2022
Kazakhstan, which supplies 40% of the uranium the world uses now, has entered a state of emergency. It is likely that uranium mining will be hit with strikes.
Via
Talk Markets
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit